Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05071209
Title Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

alveolar rhabdomyosarcoma

Advanced Solid Tumor

lymphoma

Ewing sarcoma

Therapies

BAY1895344

Age Groups: adult | child
Covered Countries USA | CAN

Additional content available in CKB BOOST